Another study demonstrated that vascular endothelial growth factor (VEGF)/chemokine ligand 18 (CCL18) from IL-4/IL-13 induced M2a type macrophage promoted the invasion of breast cancer cells via the Rho/ROCK signaling pathway, and this could be attenuated by a ROCK inhibitor [78]. Here, VEGFA is linked to breast carcinoma.